Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry 'Revision: v3.3.2' was added to the Record History, and the older 'Revision: v3.2.0' entry was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding lapse notice banner on the page was removed. The rest of the record history and trial details appear unchanged.SummaryDifference0.6%

- Check36 days agoChange DetectedVersion 18 (2025-06-11) adds updates to Study Identification, Study Status, Study Description, Arms and Interventions, and Outcome Measures. This reflects revised or newly reported trial details and status.SummaryDifference0.2%

- Check64 days agoChange DetectedKey updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).SummaryDifference11%

- Check72 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

- Check86 days agoChange DetectedUpdate: Revision changed from v3.0.1 to v3.0.2, a minor version upgrade. The 'Back to Top' element was removed, a small UI change with no impact on core content.SummaryDifference0.6%

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.